Mevacor (lovastatin) tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved March 1999

Specific Treatments:

Cardiology

Therapeutic Areas

General Information

Mevacor has been approved for the primary prevention of coronary heart disease in patients without symptomatic cardiovascular disease who have average to moderately elevated total-C and LDL-C and below average HDL-C.